Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Microbeam Technique Improves Radiation Therapy

By HospiMedica staff writers
Posted on 28 Jun 2006
Researchers report that enhancements they have made to a research form of radiation therapy that has been under evaluation for a long time could make the technique more successful and ultimately allow its use in hospitals. More...


Findings on the improved technique, which was assessed in rats, was published online June 10, 2006, in the Proceedings of the [U.S.] National Academy of Sciences. The researchers conducting the study were from the U.S. Department of Energy's Brookhaven U.S. National Laboratory and colleagues at Stony Brook University (Brookhaven, NY, USA), the IRCCS Neuromed Medical Center (Pozzilli, Italy), and Georgetown University (Washington DC, USA).

The technique, microbeam radiation therapy (MRT), previously utilized a high-intensity synchrotron x-ray source such as a superconducting wiggler at Brookhaven's National Synchrotron Light Source (NSLS) to produce parallel arrays of very thin (25-90 micrometers) planar x-ray beams instead of the unsegmented (solid), broad beams used in traditional radiation treatment.

Earlier studies performed at Brookhaven and at the European Synchrotron Radiation Facility (ESRF; Grenoble, France) demonstrated MRT's ability to control malignant tumors in animals with high radiation doses while subjecting adjacent healthy tissue to little collateral damage.

In the study, the scientists report findings that demonstrate the potential efficacy of considerably thicker microbeams, as well as a way to "interlace” the beams within a well-defined target inside the subject to increase their killing potential there, while keeping the technique's characteristic feature of sparing healthy tissue outside that target.

First, they exposed the spinal cords and brains of healthy rats to thicker (0.27-0.68 mm) microbeams at high doses of radiation and monitored the animals for signs of tissue damage. After seven months, animals exposed to beams as thick as 0.68 mm showed no or little damage to the nervous system.

Next, the scientists demonstrated the ability to "interlace” two parallel arrays of the thicker microbeams at a 90o angle to form a solid beam at a small target volume in the rats' brains, and assessed the effects of varying doses of radiation on the targeted tissue volume and the surrounding tissue using magnetic resonance imaging (MRI) scans. The MRI scans demonstrated that at a particular dose of radiation, the new configuration could produce major damage to the target volume but virtually no damage beyond the target range.



Related Links:
Brookhaven National Laboratory

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.